Yang, H., Ma, D., Liu, Y., Hu, X., Zhang, J., Wang, Z., . . . Shao, Z. (2018). Author Correction: Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer. Sci Rep.

Yang, Hai-Yuan, Ding Ma, Yi-Rong Liu, Xin Hu, Jian Zhang, Zhong-Hua Wang, Gen-Hong Di, Xi-Chun Hu, and Zhi-Ming Shao. "Author Correction: Impact of Hormone Receptor Status and Distant Recurrence-free Interval On Survival Benefits From Trastuzumab in HER2-positive Metastatic Breast Cancer." Sci Rep 2018.

Yang, Hai-Yuan, et al. "Author Correction: Impact of Hormone Receptor Status and Distant Recurrence-free Interval On Survival Benefits From Trastuzumab in HER2-positive Metastatic Breast Cancer." Sci Rep 2018.